QUIT Stock Summary and Trading Ideas (Achieve Life Sciences - Common Shares | NASDAQ:QUIT)

Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.

Achieve Life Sciences - Common Shares trades on the NASDAQ stock market under the symbol QUIT.

As of November 12, 2026, QUIT stock price declined to $6.32 with 527,417 million shares trading.

QUIT has a market cap of $651.61 million. This is considered a Small Cap stock.

The top ETF exchange traded funds that QUIT belongs to (by Net Assets): XBI, IWM, IWO, FESM, IWC.

QUIT support price is $6.45 and resistance is $6.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QUIT shares will trade within this expected range on the day.